Dr. Lamy was the PI of the CORONARY trial, a large multi centered randomized trial of off-pump CABG surgery versus on-pump CABG surgery. Dr. Lamy is also leading the COMPASS-CABG, a RCT evaluating the benefits of rivaroxaban for graft patency after CABG surgery as well as VISION-Cardiac surgery, a prospective analysis of 15,000 patients to determine the cut-off value and prognostic factor of high sensitivity troponin essays after cardiac surgery. Currently, Dr. Lamy just finished enrollment of his DEPOSITION trial on topical tranexamic acid in cardiac surgery.
Dr. Lamy also has expertise in health economics and published on large RCTs from PHRI.